Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Active not recruiting × Triple Negative Breast Neoplasms × Leflunomide × Clear all

Status

Sponsor

Conditions

Smoldering Multiple Myeloma 1

Interventions

Carboplatin 24 pembrolizumab 23 Paclitaxel 22 Cyclophosphamide 13 Gemcitabine 10 Capecitabine 9 Taxes 7 Nivolumab 7 Doxorubicin 7 Specimen Handling 6 Magnetic Resonance Spectroscopy 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 eribulin 5 atezolizumab 5 Epirubicin 5 Cisplatin 5 sacituzumab govitecan 4 olaparib 4 durvalumab 4 Radiotherapy 4 Docetaxel 4 Biopsy 4 capivasertib 3 Vinorelbine 3 Platinum 3 trastuzumab deruxtecan 2 niraparib 2 fludarabine 2 enzalutamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡